{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:25:07Z","timestamp":1773278707909,"version":"3.50.1"},"reference-count":26,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/sextrans-2017-053224","type":"journal-article","created":{"date-parts":[[2017,8,27]],"date-time":"2017-08-27T00:20:18Z","timestamp":1503793218000},"page":"561-565","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis"],"prefix":"10.1136","volume":"93","author":[{"given":"Catherine","family":"Dickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Taljaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dara Spatz","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gila","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M","family":"Grimshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,8,26]]},"reference":[{"key":"key-10.1136\/sextrans-2017-053224-1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/QCO.0000000000000058","article-title":"Preparing for an era of untreatable gonorrhea","volume":"27","author":"Barbee","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.1136\/sextrans-2017-053224-2","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization","year":"2012"},{"key":"key-10.1136\/sextrans-2017-053224-3","volume-title":"Canadian guidelines on sexually transmitted infections","author":"Public Health Agency of Canada","year":"2010"},{"key":"key-10.1136\/sextrans-2017-053224-4","volume-title":"Canadian guidelines on sexually transmitted infections","author":"Public Health Agency of Canada","year":"2013"},{"key":"key-10.1136\/sextrans-2017-053224-5","volume-title":"Guidelines for the testing and treatment of gonorrhea in Ontario, 2013","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2013"},{"key":"key-10.1136\/sextrans-2017-053224-6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2011.300283","article-title":"Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines","volume":"102","author":"Dowell","year":"2012","journal-title":"Am J Public Health"},{"key":"key-10.1136\/sextrans-2017-053224-7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/OLQ.0000000000000217","article-title":"Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012","volume":"42","author":"Kerani","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/OLQ.0000000000000061","article-title":"Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes","volume":"41","author":"Anschuetz","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/OLQ.0000000000000113","article-title":"Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011","volume":"41","author":"Lechtenberg","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amepre.2015.04.031","article-title":"Examining fluoroquinolone claims among gonorrhea-associated prescription drug claims, 2000-2010","volume":"49","author":"Owusu-Edusei","year":"2015","journal-title":"Am J Prev Med"},{"key":"key-10.1136\/sextrans-2017-053224-11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/OLQ.0000000000000073","article-title":"Provider characteristics associated with guideline-nonadherent gonorrhea treatment, Massachusetts, 2010","volume":"41","author":"Swails","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/OLQ.0000000000000310","article-title":"Adherence to Centers for Disease Control and Prevention gonococcal treatment guidelines among Chicago health care providers, 2011-2012","volume":"42","author":"Tabidze","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007776","article-title":"Diagnosis and treatment of chlamydia and gonorrhoea in general practice in England 2000-2011: a population-based study using data from the UK clinical practice research datalink","volume":"5","author":"Wetten","year":"2015","journal-title":"BMJ Open"},{"key":"key-10.1136\/sextrans-2017-053224-14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00007435-200212000-00017","article-title":"Sexually transmitted diseases in Manitoba: evaluation of physician treatment practices, STD drug utilization, and compliance with screening and treatment guidelines","volume":"29","author":"Moses","year":"2002","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007435-199708000-00002","article-title":"Factors associated with appropriate physician management of sexually transmitted diseases in an urban Canadian center","volume":"24","author":"Sellors","year":"1997","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2017-053224-16","volume-title":"Experimental and quasi-experimental designs for generalized causal inference","author":"Shadish","year":"2002"},{"key":"key-10.1136\/sextrans-2017-053224-17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"key-10.1136\/sextrans-2017-053224-18","first-page":"19833","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010","volume":"16","author":"Ison","year":"2011","journal-title":"Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull"},{"key":"key-10.1136\/sextrans-2017-053224-19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3201\/eid1701.100397","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Japan","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.1136\/sextrans-2017-053224-20","doi-asserted-by":"crossref","first-page":"19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"key-10.1136\/sextrans-2017-053224-21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2017-053224-22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"},{"key":"key-10.1136\/sextrans-2017-053224-23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1748-5908-7-38","article-title":"Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework","volume":"7","author":"French","year":"2012","journal-title":"Implement Sci"},{"key":"key-10.1136\/sextrans-2017-053224-24","doi-asserted-by":"crossref","DOI":"10.1186\/1748-5908-7-50","article-title":"Knowledge translation of research findings","volume":"7","author":"Grimshaw","year":"2012","journal-title":"Implementation Science"},{"key":"key-10.1136\/sextrans-2017-053224-25","doi-asserted-by":"crossref","first-page":"h391","DOI":"10.1136\/bmj.h391","article-title":"The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting","volume":"350","author":"Hemming","year":"2015","journal-title":"BMJ"},{"key":"key-10.1136\/sextrans-2017-053224-26","volume-title":"Canadian guidelines on sexually transmitted infections","author":"Public Health Agency of Canada","year":"2006"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2017-053224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:15:09Z","timestamp":1601115309000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2017-053224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,26]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,11,24]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/sextrans-2017-053224"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2017-053224","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,26]]}}}